FDA Person
FDANicole M. Bell
View detailed information about Nicole M. Bell, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 15 inspections of 14 companies, 2016–2025.
Inspections (15)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| November 28, 2025 | Andrew Spencer | NAI | Bioresearch Monitoring | #1297366 |
| December 12, 2024 | Jinesh B. Shah MD | NAI | Bioresearch Monitoring | #1258990 |
| December 5, 2024 | Kunjan Shah Pareshkumar, M.D. | Not classified | #1258973 | |
| December 14, 2023 | Jeffrey W. Moses, MD | NAI | Bioresearch Monitoring | #1225706 |
| December 7, 2023 | Richard A. Shlofmitz, MD | NAI | Bioresearch Monitoring | #1225704 |
| March 24, 2023 | Irma L. Febo Rodriguez, MD | NAI | Bioresearch Monitoring | #1201315 |
| September 4, 2019 | Robert Puchalski MD | NAI | Bioresearch Monitoring | #1103244 |
| August 22, 2019 | Herbert Bonkovsky, M.D. | NAI | Bioresearch Monitoring | #1102031 |
| June 22, 2017 | AnMed Health System IRB | NAI | Bioresearch Monitoring | #1017177 |
| May 19, 2017 | IQVIA | NAI | Bioresearch Monitoring | #1013132 |
| May 1, 2017 | Christopher P. Recknor MD | VAI | Bioresearch Monitoring | #1016324 |
| January 20, 2017 | Patrick Hurban | NAI | Bioresearch Monitoring | #998485 |
| January 13, 2017 | Dr. Michael Halkos | Not classified | #998390 | |
| December 16, 2016 | Christopher P. Recknor MD | NAI | Bioresearch Monitoring | #995255 |
| October 19, 2016 | Aquilla Turk, MD | Not classified | #988927 |
Documents (8)
- EIR · Michele Sewell · August 19, 2013
- 483 · Kathryn J. Lucas, M.D. · April 8, 2016
- EIR · Chiltern International Inc · July 31, 2015
- EIR · GlaxoSmithKline LLC · August 9, 2012
- EIR · PATH · August 14, 2012
- EIR · Quintiles · May 19, 2017
- 483 · Howard Conter, M.d. · November 29, 2013
- EIR · Recknor, Christopher M.D. · May 1, 2017
Person Information
Name
Nicole M. Bell
Title
issuing_officer
Role
COMPANY REP
ID: 56a038c4-9323-43ac-93d7-0b6911286b73
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.